North America Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type, Test Type, Application, and End User

Description

List of Tables

The North America radioactive tracer market was valued at US$ 8,139.16 million in 2022 and is expected to reach US$ 29,331.01 million by 2030; it is estimated to grow at a CAGR of 17.4% from 2022 to 2030.

Increasing Use of Nuclear Imaging Techniques fuel the North America Hair Extension Market

PET and SPECT are among the nuclear medicine radiology modalities employed in clinical settings. Their use is increasing as they offer accurate detection, localization, and characterization of diseases. Ionizing radiation for diagnosis and treatment benefits millions of patients globally. Radiation in medicine helps earlier diagnosis and often offers less invasive treatments for human diseases. Advanced radiation technology has opened new horizons in diagnostic and nuclear medicine, radiotherapy, and interventional radiology. According to World Health Organization, over 3,600 million diagnostic radiology examinations are performed, 37 million nuclear medicine procedures are carried out, and 7.5 million radiotherapy treatments are given annually. The development and introduction of new radiopharmaceuticals for PET/CT and SPECT/CT procedures, which are used in novel clinical applications such as neurology and orthopedics, and the growing accuracy of different tumor staging methods contribute to the growth of the radioactive tracer market. For instance, newly introduced cardiac radiopharmaceuticals such as flurpiridaz F-18 and ammonia N-13 help in more precise imaging of cardiovascular conditions. Thus, constant technological advancements for improving the quality and efficacy of nuclear imaging techniques favor the growth of the radioactive tracer market.

North America Radioactive Tracer Market Overview

The North America radioactive tracer market is segmented into the US, Canada, and Mexico. In 2022, the US held the largest share of the North America radioactive tracer market. Rising number of patients suffering from chronic conditions and viral diseases, increasing activities in research and development in advanced diagnosis method are the key factors propelling the market for radioactive tracer. Also, the increasing use of nuclear imaging techniques are favoring market expansion.

North America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

North America Radioactive Tracer Market Segmentation

The North America radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the North America radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the North America radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.

Based on end user, the North America radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the North America radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the North America radioactive tracer market is segmented into the US, Canada, and Mexico. The US dominated the North America radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, Blue Earth Diagnostics Limited, General Electric Co, and IBA Radiopharma Solutions are some of the leading players operating in the North America radioactive tracer market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America radioactive tracer market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America radioactive tracer market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00029121

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Radioactive Tracer Market - Key Industry Dynamics

4.1 Key Market Drivers:
- 4.1.1 Rising Prevalence of Chronic Diseases
- 4.1.2 Increasing Use of Nuclear Imaging Techniques
4.2 Market Restraints
- 4.2.1 Short Shelf-Life of Radioactive Tracer
- 4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
4.3 Market Opportunities
- 4.3.1 New Initiatives for Radioactive Tracer R&D
4.4 Future Trends
- 4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
4.5 Impact Analysis:

5. Radioactive Tracer Market - North America Market Analysis

5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030

6. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Tracer Types

6.1 Overview
6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
6.3 Technetium 99m and TC-97m
- 6.3.1 Overview
- 6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Iodine 131
- 6.4.1 Overview
- 6.4.2 Iodine 131: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Iron 59
- 6.5.1 Overview
- 6.5.2 Iron 59: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Lutetium- 171
- 6.6.1 Overview
- 6.6.2 Lutetium- 171: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.7 RB82 and ammonia N-13
- 6.7.1 Overview
- 6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.8 Scandium 46
- 6.8.1 Overview
- 6.8.2 Scandium 46: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.9 Seaborgium-269
- 6.9.1 Overview
- 6.9.2 Seaborgium-269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.10 Hassium -269
- 6.10.1 Overview
- 6.10.2 Hassium -269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.11 Gallium Citrate GA 67
- 6.11.1 Overview
- 6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.12 PSMA GA68
- 6.12.1 Overview
- 6.12.2 PSMA GA68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.13 FDDNP (F-18) and FDOPA (f-18)
- 6.13.1 Overview
- 6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.14 Phosphorus 32 and Chromium -51
- 6.14.1 Overview
- 6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.15 Thallium-201
- 6.15.1 Overview
- 6.15.2 Thallium-201: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.16 F-18 FDG
- 6.16.1 Overview
- 6.16.2 F-18 FDG: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.17 F-18 FAPI
- 6.17.1 Overview
- 6.17.2 F-18 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.18 GA 68 FAPI
- 6.18.1 Overview
- 6.18.2 GA 68 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.19 F-18 PSMA
- 6.19.1 Overview
- 6.19.2 F-18 PSMA: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
- 6.20.1 Overview
- 6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
6.21 Others
- 6.21.1 Overview
- 6.21.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Test Type

7.1 Overview
7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 PET
- 7.3.1 Overview
- 7.3.2 PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
7.4 SPECT
- 7.4.1 Overview
- 7.4.2 SPECT: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Application.

8.1 Overview
8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Oncology
- 8.3.1 Overview
- 8.3.2 Oncology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Pulmonary
- 8.4.1 Overview
- 8.4.2 Pulmonary: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Neurology
- 8.5.1 Overview
- 8.5.2 Neurology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
- 8.6.1 Overview
- 8.6.2 Cardiology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Radioactive Tracer Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals and Clinics
- 9.3.1 Overview
- 9.3.2 Hospitals and Clinics: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Centers
- 9.4.1 Overview
- 9.4.2 Diagnostic Centers: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Academic and Research Institutes
- 9.5.1 Overview
- 9.5.2 Academic and Research Institutes: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Radioactive Tracer Market - Country Analysis

10.1 North America Radioactive Tracer Market, Revenue and Forecast To 2030
- 10.1.1 Overview
- 10.1.2 North America Radioactive Tracer Market, by Country
  - 10.1.2.1 US
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 US Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.1.3 US Radioactive Tracer Market, by Tracer Types
    - 10.1.2.1.4 US Radioactive Tracer Market, by Test Type
    - 10.1.2.1.5 US Radioactive Tracer Market, by Application
    - 10.1.2.1.6 US Radioactive Tracer Market, by End-User
  - 10.1.2.2 Canada
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 Canada Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.2.3 Canada Radioactive Tracer Market, by Tracer Types
    - 10.1.2.2.4 Canada Radioactive Tracer Market, by Test Type
    - 10.1.2.2.5 Canada Radioactive Tracer Market, by Application
    - 10.1.2.2.6 Canada Radioactive Tracer Market, by End-User
  - 10.1.2.3 Mexico
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 Mexico Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.2.3.3 Mexico Radioactive Tracer Market, by Tracer Types
    - 10.1.2.3.4 Mexico Radioactive Tracer Market, by Test Type
    - 10.1.2.3.5 Mexico Radioactive Tracer Market, by Application
    - 10.1.2.3.6 Mexico Radioactive Tracer Market, by End-User

11. Radioactive Tracer Market Industry Landscape

11.1 Overview
11.2 Organic Developments
- 11.2.1 Overview
11.3 Inorganic Developments
- 11.3.1 Overview

12. Radioactive Tracer Market, Key Company Profiles

12.1 Rotem Industries Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Invicro LLC
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Cardinal Health Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Newcastle University
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Novartis AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Curium
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Blue Earth Diagnostics Limited
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 General Electric Co
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 IBA Radiopharma Solutions
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms